Abstract
Aim:
SM934 is a novel water-soluble artemisinin derivative with immunoregulatory activities that has been used to treat murine lupus nephritis. In the current study, we investigated the effects of SM934 on rat experimental membranous nephropathy.
Methods:
Passive Heymann nephritis (PHN) was induced in SD rats by intraperitoneal injection of anti-Fx1A serum. The rats were orally administered SM934 (12.5 and 25 mg·kg−1·d−1) or prednisolone (5 mg·kg−1·d−1) for 28 d. Blood and urine sample, and kidney tissue were collected for analyses. Human complement C3a-induced injury of HK-2 cells was used for in vitro experiments.
Results:
Treatment of PHN rats with SM934 or prednisolone attenuated the progression of glomerulonephritis and renal fibrosis, as evidenced by the reduced level of proteinuria and circulating antibodies, as well as by the reduced immune complex deposition, reversed podocyte injuries, and attenuated tubulointerstitial fibrosis in the kidneys. Furthermore, the two drugs suppressed TGF-β1 expression and Smad2/3 phosphorylation, and increased Smad7 expression in the kidneys. The two doses of SM934 produced almost identical therapeutic effects on PHN rats. Pretreatment with SM934 or a C3a receptor antagonist blocked the C3a-induced epithelial-mesenchymal transition in HK-2 cells in vitro.
Conclusion:
SM934 ameliorates kidney injury and attenuates the tubulointerstitial fibrosis in PHN rats by down-regulation of the TGF-β1/Smad signaling pathway.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Pan X, Xu J, Ren H, Zhang W, Xu Y, Shen P, et al. Changing spectrum of biopsy-proven primary glomerular diseases over the past 15 years: a single-center study in China. Contrib Nephrol 2013; 181: 22–30.
Glassock RJ . The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis 2010; 56: 157–67.
Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A, et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002; 346: 2053–60.
Beck LH, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-Type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11–21.
Barbour S, Reich H, Cattran D . Short-term complications of membranous nephropathy. Contrib Nephrol 2013; 181: 143–51.
Liu Y . Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006; 69: 213–7.
Fervenza FC, Sethi S, Specks U . Idiopathic membranous nephropathy: diagnosis and treatment. Clin J Am Soc Nephrol 2008; 3: 905–19.
Liu Y . Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 2011; 7: 684–96.
Liu Y . Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Society Nephrol 2004; 15: 1–12.
Tang Z, Lu B, Hatch E, Sacks SH, Sheerin NS . C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. J Am Society Nephrol 2009; 20: 593–603.
Loverre A, Tataranni T, Castellano G, Divella C, Battaglia M, Ditonno P, et al. IL-17 expression by tubular epithelial cells in renal transplant recipients with acute antibody-mediated rejection. Am J Transplant 2011; 11: 1248–59.
Jefferson JA, Pippin JW, Shankland SJ . Experimental models of membranous nephropathy. Drug Discov Today Dis Models 2010; 7: 27–33.
Kerjaschki D, Farquhar MG . The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci U S A 1982; 79: 5557–61.
Kerjaschki D, Farquhar MG . Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. J Exp Med 1983; 157: 667–86.
Shankland SJ, Pippin J, Pichler RH, Gordon KL, Friedman S, Gold LI, et al. Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy. Kidney Int 1996; 50: 116–24.
Li X, Li TT, Zhang XH, Hou LF, Yang XQ, Zhu FH, et al. Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell. PLoS One 2013; 8: e74108.
Hou LF, He SJ, Li X, Wan CP, Yang Y, Zhang XH, et al. SM934 treated lupus-prone NZB x NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development. PLoS One 2012; 7: e32424.
Hou LF, He SJ, Li X, Yang Y, He PL, Zhou Y, et al. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses. Arthritis Rheum 2011; 63: 2445–55.
Edgington TS, Glassock RJ, Watson JI, Dixon FJ . Characterization and isolation of specific renal tubular epithelial antigens. J Immunol 1967; 99: 1199–210.
He SJ, Lin ZM, Wu YW, Bai BX, Yang XQ, He PL, et al. Therapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZBxNZW F1 mice via interference with TLR-mediated APC response. Acta Pharmacol Sin 2014; 35: 219–29.
Shankland SJ, Ly H, Thai K, Scholey JW . Increased glomerular capillary pressure alters glomerular cytokine expression. Circ Res 1994; 75: 844–53.
Suddek GM, El-Kenawi AE, Abdel-Aziz A, El-Kashef HA . Celecoxib, a selective cyclooxygenase-2 inhibitor, attenuates renal injury in a rat model of cisplatin-induced nephrotoxicity. Chemotherapy 2011; 57: 321–6.
Saad SY, Al-Rikabi AC . Protection effects of taurine supplementation against cisplatin-induced nephrotoxicity in rats. Chemotherapy 2002; 48: 42–8.
Raychowdhury R, Zheng G, Brown D, McCluskey RT . Induction of Heymann nephritis with a gp330/megalin fusion protein. Am J Pathol 1996; 148: 1613–23.
Makker SP, Tramontano A . Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis-implications for the pathogenesis of idiopathic human membranous glomerulonephritis. J Pathol 2006; 210: 282–7.
Jefferson JA, Nelson PJ, Najafian B, Shankland SJ . Podocyte disorders: Core Curriculum 2011. Am J Kidney Dis 2011; 58: 666–77.
Haraldsson B, Jeansson M . Glomerular filtration barrier. Curr Opin Nephrol Hypertens 2009; 18: 331–5.
Herrmann A, Tozzo E, Funk J . Semi-automated quantitative image analysis of podocyte desmin immunoreactivity as a sensitive marker for acute glomerular damage in the rat puromycin aminonucleoside nephrosis (PAN) model. Exp Toxicol Pathol 2012; 64: 45–9.
Konkimalla VB, Blunder M, Korn B, Soomro SA, Jansen H, Chang W, et al. Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells. Nitric Oxide 2008; 19: 184–91.
Wang Z, Qiu J, Guo TB, Liu A, Wang Y, Li Y, et al. Anti-inflammatory properties and regulatory mechanism of a novel derivative of artemisinin in experimental autoimmune encephalomyelitis. J Immunol 2007; 179: 5958–65.
Salant DJ, Darby C, Couser WG . Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals. J Clin Invest 1980; 66: 71–81.
Yuan H, Takeuchi E, Taylor GA, McLaughlin M, Brown D, Salant DJ . Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy. J Am Soc Nephrol 2002; 13: 946–56.
Tang S, Leung JC, Abe K, Chan KW, Chan LY, Chan TM, et al. Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 2003; 111: 515–27.
Morigi M, Macconi D, Zoja C, Donadelli R, Buelli S, Zanchi C, et al. Protein overload-induced NF-kappaB activation in proximal tubular cells requires H2O2 through a PKC-dependent pathway. J Am Soc Nephrol 2002; 13: 1179–89.
Bonegio RG, Fuhro R, Wang Z, Valeri CR, Andry C, Salant DJ, et al. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy. J Am Soc Nephrol 2005; 16: 2063–72.
Bottinger EP . TGF-beta in renal injury and disease. Semin Nephrol 2007; 27: 309–20.
Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, et al. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 1993; 68: 154–63.
Wang W, Huang XR, Li AG, Liu F, Li JH, Truong LD, et al. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7. J Am Soc Nephrol 2005; 16: 1371–83.
Huang XR, Chung AC, Zhou L, Wang XJ, Lan HY . Latent TGF-beta1 protects against crescentic glomerulonephritis. J Am Soc Nephrol 2008; 19: 233–42.
Donadelli R, Abbate M, Zanchi C, Corna D, Tomasoni S, Benigni A, et al. Protein traffic activates NF-κB gene signaling and promotes MCP-1-dependent interstitial inflammation. Am J Kidney Dis 2000; 36: 1226–41.
Nangaku M . Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med 2004; 43: 9–17.
Wang Y, Wang Y, Cao Q, Zheng G, Lee VW, Zheng D, et al. By homing to the kidney, activated macrophages potently exacerbate renal injury. Am J Pathol 2008; 172: 1491–9.
Ko GJ, Boo CS, Jo SK, Cho WY, Kim HK . Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant 2008; 23: 842–52.
Acknowledgements
This work was supported by the grants of National Natural Science Foundation of China (NSFC, No 81273524, 81322049, and 81273525), National Science & Technology Major Project “New Drug Creation and Manufacturing Program”, China (No 2014ZX09101002) and National Key Basic Research Programme (973 Programme, No 2014CB541906).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Li, Tt., Zhang, Xh., Jing, Jf. et al. Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy. Acta Pharmacol Sin 36, 188–199 (2015). https://doi.org/10.1038/aps.2014.134
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2014.134
Keywords
This article is cited by
-
Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
Trials (2022)
-
Artemisinin derivative SM934 in the treatment of autoimmune and inflammatory diseases: therapeutic effects and molecular mechanisms
Acta Pharmacologica Sinica (2022)
-
The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4/NF-κB/NLRP3 signaling
Acta Pharmacologica Sinica (2021)
-
Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages
Acta Pharmacologica Sinica (2018)
-
(5R)-5-hydroxytriptolide ameliorates anti-glomerular basement membrane glomerulonephritis in NZW mice by regulating Fcγ receptor signaling
Acta Pharmacologica Sinica (2018)
